Metformin as an Anticancer Agent

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works

mTOR Signaling in Growth, Metabolism, and Disease

Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555 · see citing works

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action

Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · see citing works

AMPK: guardian of metabolism and mitochondrial homeostasis

Herzig, S., & Shaw, R. J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,094 · see citing works

TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival

Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · see citing works

AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint

Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · see citing works

The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · see citing works

Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids

Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464 · see citing works

Metformin and reduced risk of cancer in diabetic patients

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · see citing works

Diabetes and Cancer

Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366 · see citing works

Understanding the Intersections between Metabolism and Cancer Biology

Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works

The mechanisms of action of metformin

Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287 · see citing works

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · see citing works

A mammalian protein targeted by G1-arresting rapamycin–receptor complex

Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053 · see citing works

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · see citing works

The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · see citing works

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · see citing works

Cellular and molecular mechanisms of metformin: an overview

Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720 · see citing works

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.

Vézina, C., KUDELSKI, A., & Sehgal, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,691 · see citing works

Human Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by Complementation

King, M. P., & Attardi, G. M. (1989) · Science · doi:10.1126/science.2814477 · Cited by 1,659 · see citing works

RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509 · see citing works

Metformin: from mechanisms of action to therapies

Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501 · see citing works

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I

El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · see citing works

An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis

Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388 · see citing works

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

(1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90040-d · Cited by 1,386 · see citing works

Regulation of TORC1 by Rag GTPases in nutrient response

Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., & Guan, K.-L. (2008) · Nature Cell Biology · doi:10.1038/ncb1753 · Cited by 1,349 · see citing works

Metformin—mode of action and clinical implications for diabetes and cancer

Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,345 · see citing works

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284 · see citing works

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · see citing works

Metformin Inhibits Hepatic Gluconeogenesis in Mice Independently of the LKB1/AMPK Pathway via a Decrease in Hepatic Energy State

Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · see citing works

Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells

Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E., & Vander Heiden, M. G. (2015) · Cell · doi:10.1016/j.cell.2015.07.017 · Cited by 1,173 · see citing works

Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations

Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173 · see citing works

Metformin as a tool to target aging

Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096 · see citing works

Metformin: An Update

Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · see citing works

A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1

Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · see citing works

Diabetes and Cancer: A Consensus Report

Giovannucci, E. L., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,065 · see citing works

Rheb Binds and Regulates the mTOR Kinase

Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005 · see citing works

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Shu, Y., Sheardown, S. A., Brown, C., Owen, R., Zhang, S., Castro, R. A., Ianculescu, A. G., Lin, Y., Lo, J. C.-M., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 971 · see citing works

Regulation of mammalian nucleotide metabolism and biosynthesis

Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959 · see citing works

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933 · see citing works

Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1

Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918 · see citing works

Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin

Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893 · see citing works

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889 · see citing works

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887 · see citing works

The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis

Liang, J., Shao, S. H., Xu, Z.-X., Hennessy, B. T., Ding, Z., Larrea, M. D., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 868 · see citing works

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

Miller, R., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 828 · see citing works

Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome

Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A., Takahashi, H., Cantley, L., & Manning, B. (2014) · Cell · doi:10.1016/j.cell.2013.11.049 · Cited by 787 · see citing works

Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria

Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J. (2014) · Biochemical Journal · doi:10.1042/bj20140620 · Cited by 661 · see citing works

mTORC1 signaling and the metabolic control of cell growth

Ben‐Sahra, I., & Manning, B. D. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.02.012 · Cited by 641 · see citing works

AMPK as a Therapeutic Target for Treating Metabolic Diseases

Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 620 · see citing works

TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1

Dibble, C. C., Elis, W., Menon, S., Qin, W., Klekota, J., Asara, J. M., Finan, P. M., Kwiatkowski, D. J., Murphy, L. O., & Manning, B. D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.009 · Cited by 612 · see citing works

A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis

Carling, D., Zammit, V. A., & Hardie, D. G. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80292-2 · Cited by 599 · see citing works

The Folliculin Tumor Suppressor Is a GAP for the RagC/D GTPases That Signal Amino Acid Levels to mTORC1

Tsun, Z.-Y., Bar-Peled, L., Chantranupong, L., Zoncu, R., Wang, T., Kim, C., Spooner, E., & Sabatini, D. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.016 · Cited by 565 · see citing works

The Lysosomal v-ATPase-Ragulator Complex Is a Common Activator for AMPK and mTORC1, Acting as a Switch between Catabolism and Anabolism

Zhang, C., Jiang, B., Li, M., Zhu, M., Peng, Y., Zhang, Y., Wu, Y., Li, T. Y., Yu, L., Lu, Z., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.014 · Cited by 546 · see citing works

Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors

Tabernero, J. M., Rojo, F., Calvo, E., Burris, H. A., Judson, I. R., Hazell, K., Martinelli, E., y Cajal, S. R., Jones, S. F., Vidal, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5482 · Cited by 537 · see citing works

Rapalogs and mTOR inhibitors as anti-aging therapeutics

Lamming, D. W., Ye, L., Sabatini, D. M., & Baur, J. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64099 · Cited by 531 · see citing works

Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J. D., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 497 · see citing works

AMPK in skeletal muscle function and metabolism

Kjøbsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M.-N., Pehmøller, C. K., Shum, M., Marette, A., Mounier, R., Treebak, J. T., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700442r · Cited by 496 · see citing works

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., & Wondisford, F. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.016 · Cited by 479 · see citing works

Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor

Rodrik-Outmezguine, V. S., Okaniwa, M., Yao, Z., Novotny, C. J., McWhirter, C., Banaji, A., Won, H., Wong, W., Berger, M., de Stanchina, E., et al. (2016) · Nature · doi:10.1038/nature17963 · Cited by 479 · see citing works

Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis

Campbell, J. M., Bellman, S. M., Stephenson, M. D., & Lisy., K. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.08.003 · Cited by 455 · see citing works

Metformin Action: Concentrations Matter

He, L., & Wondisford, F. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.003 · Cited by 448 · see citing works

Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse

Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418 · see citing works

Targeting AMPK for cancer prevention and treatment

Li, W., Saud, S. M., Young, M. R., Chen, G., & Hua, B. (2015) · Oncotarget · doi:10.18632/oncotarget.3629 · Cited by 355 · see citing works

Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial

Higurashi, T., Hosono, K., Takahashi, H., Komiya, Y., Umezawa, S., Sakai, E., Uchiyama, T., Taniguchi, L., Hata, Y., Uchiyama, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00565-3 · Cited by 331 · see citing works

Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Sakai, E., Uchiyama, T., Suzuki, K., Iida, H., Sakamoto, Y., Yoneda, K., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0186 · Cited by 311 · see citing works

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

Hadad, S. M., Iwamoto, T., Jordan, L. B., Purdie, C. A., Bray, S. E., Baker, L., Jellema, G. L., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293 · see citing works

Repurposing metformin: an old drug with new tricks in its binding pockets

Pryor, R., & Cabreiro, F. (2015) · Biochemical Journal · doi:10.1042/bj20150497 · Cited by 280 · see citing works

Metformin activates AMPK through the lysosomal pathway

Zhang, C.-S., Li, M., Ma, T., Zong, Y., Cui, J., Feng, J.-W., Wu, Y.-Q., Lin, S.-Y., & Lin, S.-C. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.003 · Cited by 280 · see citing works

Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice

Cokorinos, E., Delmore, J. E., Reyes, A. R., Albuquerque, B., Kjøbsted, R., Eskesen, N. O., Tran, J.-L., Jatkar, A., Cialdea, K., Esquejo, R. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.010 · Cited by 267 · see citing works

AMP as a Low-Energy Charge Signal Autonomously Initiates Assembly of AXIN-AMPK-LKB1 Complex for AMPK Activation

Zhang, Y., Guo, H., Zhang, C., Lin, S., Yin, Z., Peng, Y., Luo, H., Shi, Y., Lian, G., Zhang, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.005 · Cited by 266 · see citing works

Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells

Janzer, A., German, N. J., Gonzalez-Herrera, K. N., Asara, J. M., Haigis, M. C., & Struhl, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409844111 · Cited by 264 · see citing works

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

Niraula, S., Dowling, R. J. O., Ennis, M., Chang, M. C., Done, S. J., Hood, N., Escallón, J., Leong, W. L., McCready, D. R., Reedijk, M., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2223-1 · Cited by 238 · see citing works

Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers

Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E. R., & Locasale, J. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.005 · Cited by 228 · see citing works

An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. Elegans and Cancer

Wu, L., Zhou, B., Oshiro-Rapley, N., Li, M., Paulo, J. A., Webster, C. M., Mou, F., Kacergis, M. C., Talkowski, M. E., Carr, C. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.055 · Cited by 227 · see citing works

AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development

Boudaba, N., Marion, A., Huet, C., Pierre, R., Viollet, B., & Foretz, M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.008 · Cited by 213 · see citing works

Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells

Cheng, G., Zielonka, J., Ouari, O., López, M., McAllister, D. M., Boyle, K., Barrios, C. S., Weber, J. J., Johnson, B. D., Hardy, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2534 · Cited by 212 · see citing works

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Fendt, S., Bell, E. L., Keibler, M. A., Davidson, S. M., Wirth, G. J., Fiske, B. P., Mayers, J. R., Schwab, M. G., Bellinger, G., Csibi, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0080 · Cited by 196 · see citing works

Keeping the home fires burning: AMP-activated protein kinase

Hardie, D. G. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0774 · Cited by 187 · see citing works

Metabolic alterations and targeted therapies in prostate cancer

Flavin, R., Zadra, G., & Loda, M. F. (2010) · The Journal of Pathology · doi:10.1002/path.2809 · Cited by 177 · see citing works

Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)*

Cao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R. N., Radovick, S., Wondisford, F. E., & He, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567271 · Cited by 169 · see citing works

Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects

Riedmaier, A. E., Fisel, P., Nies, A. T., Schaeffeler, E., & Schwab, M. G. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.005 · Cited by 161 · see citing works

Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity

Ford, R. J., Fullerton, M. D., Pinkosky, S. L., Day, E. A., Scott, J. W., Oakhill, J. S., Bujak, A. L., Smith, B. K., Crane, J. D., Blümer, R. M. E., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150125 · Cited by 160 · see citing works

In Vivo Imaging of Human 11 C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses

Gormsen, L. C., Sundelin, E. I. O., Jensen, J., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Christensen, M. M. H., Brøsen, K., Frøkiær, J., & Jessen, N. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.177774 · Cited by 145 · see citing works

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer

Schuler, K., Rambally, B. S., DiFurio, M. J., Sampey, B. P., Gehrig, P. A., Makowski, L., & Bae-Jump, V. L. (2014) · Cancer Medicine · doi:10.1002/cam4.353 · Cited by 136 · see citing works

Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism

Cuyàs, E., Fernández‐Arroyo, S., Verdura, S., Garcia, R., Štursa, J., Werner, L., Blanco‐González, E., Montes‐Bayón, M., Joven, J., Viollet, B., et al. (2017) · Oncogene · doi:10.1038/onc.2017.367 · Cited by 120 · see citing works

Targeting LKB1 signaling in cancer

Korsse, S. E., Peppelenbosch, M. P., & van Veelen, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.006 · Cited by 107 · see citing works

Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism

Kim, J. H., Lee, K. J., Seo, Y., Kwon, J.-H., Yoon, J. P., Kang, J. Y., Lee, H. J., Park, S. J., Hong, S. P., Cheon, J. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18762-4 · Cited by 102 · see citing works

Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells

Galdieri, L. C., Gatla, H. R., Vancurova, I., & Vančura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.742247 · Cited by 93 · see citing works

From rapalogs to anti-aging formula

Blagosklonny, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18033 · Cited by 83 · see citing works

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX

Cuyàs, E., Verdura, S., Llorach-Parés, L., Fernández‐Arroyo, S., Luciano‐Mateo, F., Cabré, N., Štursa, J., Werner, L., Martı́n-Castillo, B., Viollet, B., et al. (2018) · Aging Cell · doi:10.1111/acel.12772 · Cited by 79 · see citing works

Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer

Kalinsky, K. M., Crew, K. D., Refice, S., Xiao, T., Wang, A., Feldman, S. M., Taback, B., Ahmad, A., Cremers, S., Hibshoosh, H. H., et al. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.889706 · Cited by 78 · see citing works

Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies

Zhou, X., Xue, W., Ding, X., Li, L., Dou, M., Zhang, W., Lv, Z., Fan, Z., Zhao, J., & Wang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16973 · Cited by 75 · see citing works

A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer

Joshua, A. M., Zannella, V. E., Downes, M. R., Bowes, B., Hersey, K. M., Koritzinsky, M., Schwab, M. G., Hofmann, U., Evans, A., van der Kwast, T., et al. (2014) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2014.20 · Cited by 74 · see citing works

Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer

Boukalová, Š., Štursa, J., Werner, L., Ezrova, Z., Černý, J., Bezawork‐Geleta, A., Pecinová, A., Dong, L., Drahota, Z., & Neužil, J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-1021 · Cited by 73 · see citing works

Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?

Baur, J. A., & Birnbaum, M. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.013 · Cited by 72 · see citing works

5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo

Hasenour, C. M., Ridley, D. E., Hughey, C. C., James, F. D., Donahue, E. P., Shearer, J., Viollet, B., Foretz, M., & Wasserman, D. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528232 · Cited by 69 · see citing works

New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK

Zadra, G., Priolo, C., Patnaik, A., & Loda, M. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1955 · Cited by 67 · see citing works

Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways

Ikhlas, S., & Ahmad, M. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.029 · Cited by 64 · see citing works

Metformin-induced anticancer activities: recent insights

Safe, S. H., Nair, V., & Karki, K. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0271 · Cited by 61 · see citing works

Metformin in breast cancer - an evolving mystery

Camacho, L., Dasgupta, A., & Jiralerspong, S. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0598-8 · Cited by 59 · see citing works

Serendipity in Cancer Drug Discovery: Rational or Coincidence?

Prasad, S., Gupta, S. C., & Aggarwal, B. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.004 · Cited by 59 · see citing works

Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus

Chak, A., Buttar, N. S., Foster, N. R., Seisler, D. K., Marcon, N. E., Schoen, R. E., Cruz-Correa, M. R., Falk, G. W., Sharma, P., Hur, C., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.040 · Cited by 48 · see citing works

Metformin: A Bridge between Diabetes and Prostate Cancer

Zingales, V., Distefano, A., Raffaele, M., Zanghì, A., Barbagallo, I. A., & Vanella, L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00243 · Cited by 46 · see citing works

Pyruvate blocks expression of sensitivity to antimycin A and chloramphenicol

Harris, M. (1980) · Somatic Cell Genetics · doi:10.1007/bf01538969 · Cited by 30 · see citing works

Metformin induces protein acetylation in cancer cells

Vančura, A., & Vancurova, I. (2017) · Oncotarget · doi:10.18632/oncotarget.17829 · Cited by 18 · see citing works

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

Hou, J., Karin, M., & Sun, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00459-9 · Cited by 376 · see citing works

Role of mitochondria in the mechanism(s) of action of metformin

Vial, G., Detaille, D., & Guigas, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00294 · Cited by 303 · see citing works

Obesity, Diabetes, and Increased Cancer Progression

Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 312 · see citing works

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278 · see citing works

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 282 · see citing works

Metformin as Anti-Aging Therapy: Is It for Everyone?

Soukas, A. A., Hao, H., & Wu, L. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.07.015 · Cited by 260 · see citing works

Oncometabolites in renal cancer

Yong, C., Stewart, G. D., & Frezza, C. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0210-z · Cited by 212 · see citing works

Metabolic reprogramming in prostate cancer

Ahmad, F., Cherukuri, M. K., & Choyke, P. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01435-5 · Cited by 221 · see citing works

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing

Hua, Y., Zheng, Y., Yao, Y., Jia, R., Ge, S., & Zhuang, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04263-8 · Cited by 207 · see citing works

Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications

Feng, J., Wang, X., Ye, X., Arés, I., López-Torres, B., Martínez, M., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106114 · Cited by 198 · see citing works

Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

Chen, S., Gan, D., Lin, S., Zhong, Y., Chen, M., Zou, X., Shao, Z., & Xiao, G. (2022) · Theranostics · doi:10.7150/thno.71360 · Cited by 197 · see citing works

Insulin Resistance and Cancer: In Search for a Causal Link

CHIEFARI, E. D., Mirabelli, M., Vignera, S. L., Tanyolaç, S., FOTI, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 175 · see citing works

The Current and Potential Therapeutic Use of Metformin—The Good Old Drug

Drzewoski, J., & Hanefeld, M. (2021) · Pharmaceuticals · doi:10.3390/ph14020122 · Cited by 165 · see citing works

Tumour metabolism and its unique properties in prostate adenocarcinoma

Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 154 · see citing works

Metformin-based nanomedicines for reprogramming tumor immune microenvironment

Liu, J., Li, X., Li, Y., Gong, Q., & Luo, K. (2024) · Theranostics · doi:10.7150/thno.104872 · Cited by 114 · see citing works

Antiaging agents: safe interventions to slow aging and healthy life span extension

Liu, J. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00339-y · Cited by 107 · see citing works

Metformin: Activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action

Goel, S. K., Singh, R. P., Singh, V., Singh, H., Kumari, P., Chopra, H., Sharma, R., Nepovimová, E., Vališ, M., Kuča, K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1022739 · Cited by 112 · see citing works

Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications

Zhang, X., Zhao, Y., Chen, S., & Shao, H. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12838 · Cited by 93 · see citing works

An injectable and pH-responsive hyaluronic acid hydrogel as metformin carrier for prevention of breast cancer recurrence

Zheng, Z., Yang, X. H., Zhang, Y., Zu, W., Wen, M., Liu, T., Zhou, C., & Li, L. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120493 · Cited by 92 · see citing works

Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis

Dong, Y., Hu, H., Zhang, X., Zhang, Y., Sun, X., Wang, H., Kan, W., Tan, M., Shi, H., Zang, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01302-6 · Cited by 95 · see citing works

Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems

Tavakol, S., Ashrafizadeh, M., Deng, S., Azarian, M., Abdoli, A., Motavaf, M., Poormoghadam, D., Khanbabaei, H., Afshar, E. G., Mandegary, A., et al. (2019) · Biomolecules · doi:10.3390/biom9100530 · Cited by 89 · see citing works

Metformin: An old drug against old age and associated morbidities

Salvatore, T., Pafundi, P. C., Morgillo, F., Liello, R. D., Galiero, R., Nevola, R., Marfella, R., Monaco, L., Rinaldi, L., Adinolfi, L. E., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108025 · Cited by 87 · see citing works

Accelerated bio‐cognitive aging in Down syndrome: State of the art and possible deceleration strategies

Franceschi, C., Garagnani, P., Gensous, N., Bacalini, M. G., Conte, M., & Salvioli, S. (2019) · Aging Cell · doi:10.1111/acel.12903 · Cited by 80 · see citing works

Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies

Reyes‐Castellanos, G., Masoud, R., & Carrier, A. (2020) · Biomedicines · doi:10.3390/biomedicines8080270 · Cited by 82 · see citing works

Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction

Xiao, Q., Xiao, J., Liu, J., Liu, J., Shu, G., & Yin, G. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04649-4 · Cited by 81 · see citing works

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer

Rocca, C., Soda, T., Francesco, E. D. D., Fiorillo, M., Moccia, F., Viglietto, G., Angelone, T., & Amodio, N. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04498-5 · Cited by 82 · see citing works

Metformin acts in the gut and induces gut-liver crosstalk

Tobar, N., Rocha, G. Z., Santos, A., Guadagnini, D., Assalin, H. B., de Camargo, J. A., Gonçalves, A. E. S. S., Pallis, F. R., Oliveira, A. G., Rocco, S. A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211933120 · Cited by 78 · see citing works

Visceral Obesity Promotes Lung Cancer Progression—Toward Resolution of the Obesity Paradox in Lung Cancer

Barbi, J. J., Patnaik, S. K., Pabla, S., Zollo, R. A., Smith, R. J., Sass, S. N., Srinivasan, A., Petrucci, C. M., Seager, R. J., Conroy, J. M., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.04.020 · Cited by 76 · see citing works

Metformin and Breast Cancer: Molecular Targets

Faria, J., Negalha, G. D. C., Azevedo, A., & Martel, F. (2019) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-019-09429-z · Cited by 75 · see citing works

Examining the clinical relevance of metformin as an antioxidant intervention

Buczyńska, A., Sidorkiewicz, I., Kretowski, A. J., & Adamska, A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1330797 · Cited by 72 · see citing works

Molecular biological mechanism of action in cancer therapies: Juglone and its derivatives, the future of development

Tang, Y.-T., Li, Y., Chu, P., Ma, X. D., Tang, Z. Y., & Sun, Z. L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112785 · Cited by 70 · see citing works

Metabolic heterogeneity in cancer: An overview and therapeutic implications

Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 66 · see citing works

Therapeutic Repurposing of Biguanides in Cancer

Zhao, H., Swanson, K. D., & Zheng, B. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.03.001 · Cited by 65 · see citing works

Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application

Jafari-Gharabaghlou, D., Dadashpour, M., Khanghah, O. J., Salmani-Javan, E., & Zarghami, N. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08171-w · Cited by 65 · see citing works

Reducing PD-L1 expression with a self-assembled nanodrug: an alternative to PD-L1 antibody for enhanced chemo-immunotherapy

Cai, S., Chen, Z., Wang, Y., Wang, M., Wu, J., Tong, Y., Chen, L., Lü, C., & Yang, H. (2020) · Theranostics · doi:10.7150/thno.45777 · Cited by 64 · see citing works

Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways

Guo, L., Cui, J., Wang, H., Medina, R., Zhang, S., Zhang, X., Zhuang, Z., & Lin, Y. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.11.004 · Cited by 63 · see citing works

The role of an anti-diabetic drug metformin in the treatment of endocrine tumors

Thakur, S., Daley, B., & Kłubo-Gwieździńska, J. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0083 · Cited by 62 · see citing works

Metformin prevents the pathological browning of subcutaneous white adipose tissue

Auger, C., Knuth, C. M., Abdullahi, A., Samadi, O., Parousis, A., & Jeschke, M. G. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.011 · Cited by 61 · see citing works

The evolving view of thermogenic fat and its implications in cancer and metabolic diseases

Yin, X., Chen, Y., Ruze, R., Xu, R., Song, J., Wang, C., & Xu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01178-6 · Cited by 68 · see citing works

Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes

Mu, X., Xiang, Z., Xu, Y., He, J., Lu, J., Chen, Y., Wang, X., Tu, C. R., Zhang, Y., Zhang, W., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00894-x · Cited by 59 · see citing works

The Dual-Role of Methylglyoxal in Tumor Progression – Novel Therapeutic Approaches

Leone, A., Nigro, C., Nicolò, A., Prevenzano, I., Formisano, P., Bèguinot, F., & Miele, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.645686 · Cited by 59 · see citing works

Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells

Wu, X., Yeerna, H., Goto, Y., Ando, T., Wu, V. H., Zhang, X., Wang, Z., Amornphimoltham, P., Murphy, A. N., Tamayo, P., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3525 · Cited by 54 · see citing works

The Use of Metformin to Increase the Human Healthspan

Piskovatska, V., Storey, K. B., Vaiserman, A. M., & Lushchak, O. V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_13 · Cited by 54 · see citing works

Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy

Zhao, B., Luo, J., Wang, Y., Zhou, L., Che, J., Wang, F., Peng, S., Zhang, G., & Shang, P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9290728 · Cited by 53 · see citing works

Design and fabrication of a dual-drug loaded nano-platform for synergistic anticancer and cytotoxicity effects on the expression of leptin in lung cancer treatment

Alagheband, Y., Jafari-Gharabaghlou, D., Imani, M., Mousazadeh, H., Dadashpour, M., Firouzi‐Amandi, A., & Zarghami, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103389 · Cited by 51 · see citing works

Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

Feng, J., Lu, H. J., Ma, W., Tian, W., Lu, Z., Yang, H., Cai, Y., Cai, P., Sun, Y., Zhou, Z., et al. (2022) · Protein & Cell · doi:10.1007/s13238-022-00906-6 · Cited by 49 · see citing works

TME-triggered MnSiO3@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy

Zhang, J., Chen, L., Wei, Z., Yang, W., Ge, W., Qu, X., Si, W., Wang, W., Mou, X., & Dong, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121682 · Cited by 49 · see citing works

Metformin attenuates cadmium-induced neuronal apoptosis in vitro via blocking ROS-dependent PP5/AMPK-JNK signaling pathway

Chen, X., Wu, W., Gong, B., Hou, L., Dong, X., Xu, C., Zhao, R., Yu, Q., Zhou, Z., Huang, S., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108065 · Cited by 48 · see citing works

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors

Dąbrowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041680 · Cited by 47 · see citing works

Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors

Liu, W., Wang, Y., Luo, J., Liu, M., & Luo, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586760 · Cited by 45 · see citing works

Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy

Chen, L., Liao, F., Jiang, Z., Zhang, C., Wang, Z., Luo, P., Jiang, Q., Wu, J., Wang, Q., Luo, M., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15149 · Cited by 45 · see citing works

Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study

Luo, S., Schooling, C. M., Wong, I. C. K., & Yeung, S. L. A. (2020) · Diabetologia · doi:10.1007/s00125-020-05243-z · Cited by 44 · see citing works

Targeting translation: a promising strategy for anticancer metallodrugs

Ortega, E., Vigueras, G., Ballester, F. J., & Ruiz, J. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214129 · Cited by 44 · see citing works

Metformin accelerates zebrafish heart regeneration by inducing autophagy

Xie, F., Xu, S., Lü, Y., Wong, K. F., Sun, L., Hasan, K. M. M., Ma, A. C. H., Tse, G., Manno, S. H. C., Tian, L., et al. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00172-w · Cited by 44 · see citing works

Self-Adjuvanting Polyguanidine Nanovaccines for Cancer Immunotherapy

Zhang, X., Wang, K., Zhao, Z., Shan, X., Wang, Y., Feng, Z., Li, B., Luo, C., Chen, X. S., & Sun, J. (2024) · ACS Nano · doi:10.1021/acsnano.3c11637 · Cited by 43 · see citing works

Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass

Elksnis, A., Martinell, M., Eriksson, O., & Espes, D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00107 · Cited by 44 · see citing works

Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer

Cheng, T., Wang, C., Lu, Q., Cao, Y., Yu, W., Li, W., Liu, B., Gao, X. J., Lü, J., & Pan, X. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.010 · Cited by 41 · see citing works

Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin

Meng, J., Han, J., Wang, X., Wu, T., Zhang, H., An, H., Qin, L., Sun, Y., Zhong, W., Yang, C., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106661 · Cited by 41 · see citing works

Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes

Khan, H., Anshu, A., Prasad, A. K., Roy, S., Jeffery, J. J., Kittipongdaja, W., Yang, D. T., & Schieke, S. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.007 · Cited by 41 · see citing works

Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity

Grønningsæter, I. S., Reikvam, H., Aasebø, E., Bartaula-Brevik, S., Tvedt, T. H. A., Bruserud, Ø., & Hatfield, K. J. (2020) · Cells · doi:10.3390/cells9051155 · Cited by 40 · see citing works

Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression

Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 43 · see citing works

The biflavonoids as protein tyrosine phosphatase 1B inhibitors from Selaginella uncinata and their antihyperglycemic action

Xu, J., Yang, L., Wang, R., Zeng, K., Fan, B., & Zhao, Z. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104255 · Cited by 39 · see citing works

Targeting glioma-initiating cells via the tyrosine metabolic pathway

Yamashita, D., Bernstock, J. D., Elsayed, G., Sadahiro, H., Mohyeldin, A., Chagoya, G., Ilyas, A., Mooney, J. H., Estévez-Ordoñez, D., Yamaguchi, S., et al. (2020) · Journal of neurosurgery · doi:10.3171/2019.11.jns192028 · Cited by 39 · see citing works

Single cell mass spectrometry analysis of drug-resistant cancer cells: Metabolomics studies of synergetic effect of combinational treatment

Chen, X., Sun, M., & Yang, Z. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339621 · Cited by 40 · see citing works

Nandrolone induces a stem cell-like phenotype in human hepatocarcinoma-derived cell line inhibiting mitochondrial respiratory activity

Agriesti, F., Tataranni, T., Pacelli, C., Scrima, R., Laurenzana, I., Ruggieri, V., Cela, O., Mazzoccoli, C., Salerno, M., Sessa, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58871-1 · Cited by 37 · see citing works

A responsive porous hydrogel particle-based delivery system for oncotherapy

Wen, Y., Liu, Y., Zhang, H., Zou, M., Yan, D., Chen, D., & Zhao, Y. (2019) · Nanoscale · doi:10.1039/c8nr09990a · Cited by 36 · see citing works

Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms

Vazquez-Borrego, M. C., Fuentes-Fayos, A. C., Herrera-Martínez, A. D., L‐López, F., Ibáñez‐Costa, A., Moreno-Moreno, P., Alhambra-Expósito, M. R., Barrera-Martín, A., Blanco-Acevedo, C., Dios, E., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00056 · Cited by 36 · see citing works

Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells

Kaur, P., Nagar, S., Bhagwat, M., Uddin, M., Zhu, Y. B., Vancurova, I., & Vančura, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260400 · Cited by 37 · see citing works

Metformin Intervention—A Panacea for Cancer Treatment?

Buczyńska, A., Sidorkiewicz, I., Kretowski, A. J., Zbucka-Krętowska, M., & Adamska, A. (2022) · Cancers · doi:10.3390/cancers14051336 · Cited by 36 · see citing works

Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity

Barbieri, F., Verduci, I., Carlini, V., Zona, G., Pagano, A., Mazzanti, M., & Florio, T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00135 · Cited by 34 · see citing works

Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1

Chen, H., Lin, C., Peng, T., Hu, C., Lu, C., Li, L., Wang, Y., Han, R., Feng, M., Sun, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2307-5 · Cited by 34 · see citing works

Signaling Pathways Involved in Nutrient Sensing Control in Cancer Stem Cells: An Overview

Robles‐Flores, M., Moreno-Londoño, Á. P., & Castañeda‐Patlán, M. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627745 · Cited by 33 · see citing works

FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis

He, Z., Yang, J.-B., Sui, C., Zhang, P., Wang, T., Mou, T., Sun, K., Wang, Y., Xu, Z., Li, G., et al. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109216 · Cited by 33 · see citing works

Metformin, Microbiome and Protection Against Colorectal Cancer

Jones, G. R. D., & Molloy, M. P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06390-4 · Cited by 33 · see citing works

Prostate Cancer Energetics and Biosynthesis

Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M. A., McGuire, S. E., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_10 · Cited by 31 · see citing works

The Function of Metformin in Aging-Related Musculoskeletal Disorders

Song, Y., Wu, Z., & Zhao, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865524 · Cited by 32 · see citing works

Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications

García-Sáenz, M. R., Lobaton-Ginsberg, M., & Ferreira‐Hermosillo, A. (2022) · Biomolecules · doi:10.3390/biom12040574 · Cited by 32 · see citing works

Repurposing drugs targeting metabolic diseases for cancer therapeutics

Pillai U, J., Ray, A., Maan, M., & Dutta, M. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103684 · Cited by 31 · see citing works

The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin

Kopel, J. J., Higuchi, K., Ristić, B., Sato, T., Ramachandran, S., & Ganapathy, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-65621-w · Cited by 29 · see citing works

Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)

Allende-Vega, N., Marco-Brualla, J., Falvo, P., Alexia, C., Constantinides, M., de Maudave, A. F., Coënon, L., Gitenay, D., Mitola, G., Massa, P. E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05470-x · Cited by 30 · see citing works

A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer

Chow, E., Yang, A., Chung, C. H. L., & Chan, J. C. N. (2022) · Pharmaceuticals · doi:10.3390/ph15040442 · Cited by 30 · see citing works

Insulin resistance in cancer risk and prognosis

Jacobo-Tovar, E., Medel-Sánchez, A., Durán-Castillo, C., & Guardado‐Mendoza, R. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.006 · Cited by 29 · see citing works

Insulin Resistance in Healthy U.S. Adults: Findings from the National Health and Nutrition Examination Survey (NHANES)

Caporaso, N. E., Jones, R. R., Stolzenberg‐Solomon, R. Z., Medgyesi, D. N., Kahle, L., & Graubard, B. I. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0206 · Cited by 30 · see citing works

Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression

El Massry, M., Alaeddine, L. M., Ali, L., Saad, C., & Eid, A. A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114902 · Cited by 27 · see citing works

Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway

Loos, J. A., Dávila, V. A., Brehm, K., & Cumino, A. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01808-19 · Cited by 25 · see citing works

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer

Rocca, A., Cortesi, P., Cortesi, L., Gianni, L., Matteucci, F., Fantini, L., Maestri, A., Giunchi, D. C., Cavanna, L., Ciani, R., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920985632 · Cited by 26 · see citing works

Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor‐Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance

Kim, S., Im, J. H., Kim, W., Choi, Y. J., Lee, J. Y., Kim, S. K., Kim, S. J., Kwon, S. W., & Kang, K. W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5428364 · Cited by 26 · see citing works

The Hormetic Effect of Metformin: “Less Is More”?

Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 27 · see citing works

Hyperglycemia-driven signaling bridges between diabetes and cancer

Ghareghomi, S., Arghavani, P., Mahdavi, M., Khatibi, A., García‐Jiménez, C., & Moosavi‐Movahedi, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116450 · Cited by 26 · see citing works

Metformin Reverses Hashimoto's Thyroiditis by Regulating Key Immune Events

Jia, X., Zhai, T., Qu, C., Ye, J., Zhao, J., Liu, X., Zhang, J., & Qian, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.2139/ssrn.3782444 · Cited by 25 · see citing works

Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy

Mascaraque, M., Gallego-Rentero, M., Morala, J. N., Portillo-Esnaola, M., Cuezva, J. M., González, S., Gilaberte, Y., & Juarranz, Á. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101496 · Cited by 25 · see citing works

From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease

Poznyak, A. V., Litvinova, L. S., Poggio, P., Moschetta, D., Sukhorukov, V. N., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179738 · Cited by 25 · see citing works

Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma

Wang, Y., Maurer, M. J., Larson, M. C., Allmer, C., Feldman, A. L., Bennani, N. N., Thompson, C. A., Porrata, L. F., Habermann, T. M., Witzig, T. E., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.15997 · Cited by 24 · see citing works

Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity

Park, S. H., Lee, J. H., Yun, H. J., Kim, S.-H., & Lee, J. (2024) · Annals of Laboratory Medicine · doi:10.3343/alm.2023.0443 · Cited by 24 · see citing works

Intestinal microbiota regulates anti‐tumor effect of disulfiram combined with Cu2+ in a mice model

Hu, H., Cui, L., Lu, J., Wei, K., Wei, J., Li, S., Zou, C., & Chen, T. (2020) · Cancer Medicine · doi:10.1002/cam4.3346 · Cited by 24 · see citing works

Targeting the pH Paradigm at the Bedside: A Practical Approach

Koltai, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239221 · Cited by 24 · see citing works

A Single Dose of Oral Metformin Reduces the Post-Prandial Glucose Response Through a Transient Modulation of Apical Sodium-Glucose Co-Transporter

Zubiaga, L., Briand, O., Auger, F., Touche, V., Hübert, T., Thévenet, J., Marciniak, C., Quenon, A., Bonner, C., Peschard, S., et al. (2019) · iScience · doi:10.1016/j.isci.2023.106057 · Cited by 23 · see citing works

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer

Ye, J., Cai, S., Feng, Y., Li, J., Cai, Z., Deng, Y., Liu, R., Zhu, X., Lü, J., Zhuo, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01516-2 · Cited by 24 · see citing works

Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area

Tulipano, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313068 · Cited by 25 · see citing works

Dysregulated Redox Signaling and Its Impact on Inflammatory Pathways, Mitochondrial Dysfunction, Autophagy and Cardiovascular Diseases

Pervin, M., & de Haan, J. B. (2025) · Antioxidants · doi:10.3390/antiox14111278 · Cited by 26 · see citing works

Metformin and Its Implication in Cancer Therapy

Mazilu, L., Stănculeanu, D. L., Gheorghe, A. D., Suceveanu, A., Parepa, I. R., Voinea, F., Catrinoiu, D., & Suceveanu, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88803 · Cited by 1 · see citing works

Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment

Li, M., Li, X., Zhang, H., & Lü, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01039 · Cited by 121 · see citing works

Metformin and Cancer, an Ambiguanidous Relationship

Skuli, S. J., Alomari, S., Gaitsch, H., Bakayoko, A., Skuli, N., & Tyler, B. (2022) · Pharmaceuticals · doi:10.3390/ph15050626 · Cited by 56 · see citing works

Metformin: Its emerging role in oncology

Micić, D., Cvijović, G., Trajković, V., Duntas, L. H., & Polovina, S. P. (2011) · HORMONES · doi:10.14310/horm.2002.1288 · Cited by 49 · see citing works

Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice

Олегович, К. К., Safina, Е. R., Gaimakova, D. V., Frolova, Y. S., Oganesyan, I. Y., Sadertdinova, A. G., Александровна, Н. К., Islamgulov, A. K., Karimova, A. R., Galimova, A. M., et al. (2022) · Problems of Endocrinology · doi:10.14341/probl13097 · Cited by 7 · see citing works